UBS Group’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-7
| Closed | -$36 | – | 8917 |
|
|
2023
Q3 | $36 | Buy |
+7
| New | +$36 | ﹤0.01% | 7907 |
|
|
2023
Q2 | – | Sell |
-55
| Closed | -$539 | – | 8742 |
|
|
2023
Q1 | $539 | Sell |
55
-421
| -88% | -$4.13K | ﹤0.01% | 7880 |
|
|
2022
Q4 | $1.57K | Buy |
476
+44
| +10% | +$145 | ﹤0.01% | 8637 |
|
|
2022
Q3 | $2K | Sell |
432
-439
| -50% | -$2.03K | ﹤0.01% | 8719 |
|
|
2022
Q2 | $10K | Buy |
+871
| New | +$10K | ﹤0.01% | 7002 |
|
|
2022
Q1 | – | Sell |
-358
| Closed | -$8K | – | 9828 |
|
|
2021
Q4 | $8K | Buy |
+358
| New | +$8K | ﹤0.01% | 7954 |
|
|
2018
Q4 | – | Sell |
-125
| Closed | -$11K | – | 7276 |
|
|
2018
Q3 | $11K | Buy |
125
+7
| +6% | +$616 | ﹤0.01% | 6209 |
|
|
2018
Q2 | $13K | Hold |
118
| – | – | ﹤0.01% | 6083 |
|
|
2018
Q1 | $25K | Sell |
118
-46
| -28% | -$9.75K | ﹤0.01% | 5393 |
|
|
2017
Q4 | $36K | Buy |
+164
| New | +$36K | ﹤0.01% | 5149 |
|